Literature DB >> 21921607

Cardiorenal syndrome: a complex series of combined heart/kidney disorders.

Ching Yan Goh, Grazia Vizzi, Massimo De Cal, Claudio Ronco.   

Abstract

Over the last decade, it has become increasingly clear that the cardiovascular and renal systems are interdependent. Primary disorders of either system have been shown to disturb the other system. As a result, a class of cardiorenal syndrome (CRS) has been identified where in a vicious cycle is established in which acute/chronic dysfunction of either the kidney or the heart exacerbates the loss of function in the other organ. The ADQI organization has proposed a classification derived from a consensus conference held in 2008. CRS is classified as a disorder of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other. The general definition has been expanded into five subtypes: CRS type 1 = acute worsening of heart function (acute heart failure-acute coronary syndrome) leading to kidney injury and/or dysfunction; CRS type 2 = chronic abnormalities in heart function (chronic heart failure-chronic heart disease) leading to kidney injury or dysfunction; CRS type 3 = acute worsening of kidney function (acute kidney injury) leading to heart injury and/or dysfunction; CRS type 4 = chronic kidney disease (chronic kidney disease) leading to heart injury, disease and/or dysfunction; and CRS type 5 = systemic conditions leading to simultaneous injury and/or dysfunction of heart and kidney. A major problem with previous terminology was that it did not allow for identification of pathophysiological interactions occurring in the different types of combined heart/kidney disorders. The subdivision into different subtypes seems to provide a better approach to this syndrome.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921607     DOI: 10.1159/000329233

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  19 in total

1.  Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.

Authors:  Mahboob Rahman; Dawei Xie; Harold I Feldman; Alan S Go; Jiang He; John W Kusek; James Lash; Edgar R Miller; Akinlolu Ojo; Qiang Pan; Stephen L Seliger; Susan Steigerwalt; Ray R Townsend
Journal:  Am J Nephrol       Date:  2014-11-11       Impact factor: 3.754

2.  Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.

Authors:  Silvia Pastori; Grazia Maria Virzì; Alessandra Brocca; Massimo de Cal; Anna Clementi; Giorgio Vescovo; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-02-11       Impact factor: 2.041

Review 3.  Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.

Authors:  Alberto Palazzuoli; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2011-11       Impact factor: 4.214

Review 4.  Cellular apoptosis in the cardiorenal axis.

Authors:  Grazia Maria Virzì; Anna Clementi; Claudio Ronco
Journal:  Heart Fail Rev       Date:  2016-03       Impact factor: 4.214

Review 5.  Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Claudio Ronco
Journal:  J Nephrol       Date:  2017-08-05       Impact factor: 3.902

6.  The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Tsuneo Konta; Harutoshi Tamura; Shigehiko Kato; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Tetsuro Shishido; Masafumi Watanabe
Journal:  Heart Vessels       Date:  2019-07-22       Impact factor: 2.037

7.  Cardiorenal Syndrome Type 1 May Be Immunologically Mediated: A Pilot Evaluation of Monocyte Apoptosis.

Authors:  Grazia Maria Virzì; Rossella Torregrossa; Dinna N Cruz; Chang Y Chionh; Massimo de Cal; Sachin S Soni; Massimo Dominici; Giorgio Vescovo; Mitchell H Rosner; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-01-20       Impact factor: 2.041

8.  Comorbid renal tubular damage and hypoalbuminemia exacerbate cardiac prognosis in patients with chronic heart failure.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Hiroki Takahashi; Akira Funayama; Daisuke Kinoshita; Miyuki Yokoyama; Tetsuya Takahashi; Satoshi Nishiyama; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Tsuneo Konta; Isao Kubota
Journal:  Clin Res Cardiol       Date:  2015-07-29       Impact factor: 5.460

9.  Carotid Intima-Media Thickness and Incident ESRD: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Yuanjie Pang; Yingying Sang; Shoshana H Ballew; Morgan E Grams; Gerardo Heiss; Josef Coresh; Kunihiro Matsushita
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

10.  Supramaximal elevation in B-type natriuretic peptide and its N-terminal fragment levels in anephric patients with heart failure: a case series.

Authors:  John Yc Ting; Bruce A Pussell
Journal:  J Med Case Rep       Date:  2012-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.